A complex role for the progesterone receptor in the response to vascular injury.

Clinical studies of hormone replacement therapy to prevent cardiovascular diseases have heightened interest in the cardiovascular effects of progestins. However, the role of the progesterone receptor (PR) in vascular biology has not been studied in vivo. We studied ovariectomized female PR knockout (PRKO) mice and their wild-type (WT) littermates using the mouse carotid artery injury model. Placebo-treated PRKO mice showed significantly greater vascular medial hypertrophy and vascular smooth muscle cell (VSMC) proliferation in response to vascular injury than did WT mice. Progesterone had no significant effect in the PRKO mice, but worsened the response to injury in WT mice. VSMCs cultured from PRKO mouse aortae were markedly hyperproliferative, and their growth was not affected by progesterone. In contrast to the in vivo findings, progesterone inhibited proliferation of WT-derived VSMCs. Furthermore, reintroduction of PR into PRKO-derived VSMCs using adenoviral methods restored progesterone-mediated inhibition of proliferation to these cells. This effect was reversed by the PR antagonist, RU 486. Thus, the effects of PR and progesterone differ markedly between cultured VSMCs and intact blood vessels. These data demonstrate a direct role for the PR in regulating the response to vascular injury and VSMC proliferation.

[1]  R. Karas,et al.  The protective effects of estrogen on the cardiovascular system. , 2002, The New England journal of medicine.

[2]  J. Gustafsson,et al.  Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Alessandro Sebastian Podda,et al.  Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women. , 1999, The American journal of cardiology.

[4]  M. Mendelsohn,et al.  Protective effects of estrogen on the cardiovascular system. , 1999, The American journal of cardiology.

[5]  D. Edwards,et al.  Progesterone Regulates Proliferation of Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[6]  E. Vittinghoff,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[7]  T. Clarkson.  Effects of estrogens, progestins, and androgens on coronary vasomotion and atherosclerosis. , 1998, The Journal of reproductive medicine.

[8]  R. Karas,et al.  Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway. , 1998, The Journal of clinical investigation.

[9]  E. Levin,et al.  Oestrogen and progesterone inhibit the stimulated production of endothelin-1. , 1998, The Biochemical journal.

[10]  E. Haber,et al.  Progesterone inhibits arterial smooth muscle cell proliferation , 1997, Nature Medicine.

[11]  B. O’Malley,et al.  Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo. , 1997, Endocrinology.

[12]  M. Ewen,et al.  Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4 , 1997, Molecular and cellular biology.

[13]  E. Levin,et al.  Estrogen and progesterone inhibit vascular smooth muscle proliferation. , 1997, Endocrinology.

[14]  G. Jenster,et al.  Steroid receptor induction of gene transcription: a two-step model. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Mizutani,et al.  Effects of 17β-estradiol and progesterone on migration of human monocytic THP-1 cells stimulated by minimally oxidized low-density lipoprotein in vitro , 1997 .

[16]  R. Karas,et al.  Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice , 1997, Nature Medicine.

[17]  S. Oparil,et al.  Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. , 1997, Circulation.

[18]  É. Allaire,et al.  Endothelial cell injury in cardiovascular surgery: atherosclerosis. , 1997, The Annals of thoracic surgery.

[19]  R. Bernards,et al.  CDK-Independent Activation of Estrogen Receptor by Cyclin D1 , 1997, Cell.

[20]  B. O’Malley,et al.  Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. , 1996, Molecular endocrinology.

[21]  S. Oparil,et al.  Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. , 1996, Circulation.

[22]  J. Manson,et al.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. , 1996, The New England journal of medicine.

[23]  C. Hegele-hartung,et al.  Sexual dimorphism of steroid hormone receptor messenger ribonucleic acid expression and hormonal regulation in rat vascular tissue. , 1996, Endocrinology.

[24]  K. Korach,et al.  Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. , 1996, Endocrinology.

[25]  P. Ramwell,et al.  The vascular protective effects of estrogen , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  V. Hombach,et al.  Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. , 1996, Atherosclerosis.

[27]  B. O’Malley,et al.  Reproductive phenotypes of the progesterone receptor null mutant mouse , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  P. Porter,et al.  Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. , 1996, The Journal of clinical investigation.

[29]  L. Moore,et al.  Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. , 1995, Endocrine reviews.

[30]  Y. Taketani,et al.  Regulation of the plasminogen activator/plasmin system by epidermal growth factor in cultured human endometrial cells. , 1995, Human reproduction.

[31]  Daniel Metzger,et al.  Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase , 1995, Science.

[32]  J. J. Smith,et al.  Estrogen inhibits the response-to-injury in a mouse carotid artery model. , 1995, The Journal of clinical investigation.

[33]  B. O’Malley,et al.  A nuclear hormone receptor-associated protein that inhibits transactivation by the thyroid hormone and retinoic acid receptors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Korach,et al.  Cross talk between peptide growth factor and estrogen receptor signaling systems. , 1995, Environmental health perspectives.

[35]  B. O’Malley,et al.  Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. , 1995, Genes & development.

[36]  Susan R. Johnson,et al.  Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial , 1995 .

[37]  T. Clarkson,et al.  Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. , 1994, Journal of the American College of Cardiology.

[38]  R. Karas,et al.  Human vascular smooth muscle cells contain functional estrogen receptor. , 1994, Circulation.

[39]  M. Reidy,et al.  Mouse model of arterial injury. , 1993, Circulation research.

[40]  K. Korach,et al.  Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. , 1993, Molecular endocrinology.

[41]  A. Folsom,et al.  Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women , 1993 .

[42]  Caroline S. Fox,et al.  Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.

[43]  K. Korach,et al.  Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[44]  B. O’Malley,et al.  Dopaminergic and ligand-independent activation of steroid hormone receptors. , 1991, Science.

[45]  V. Miller,et al.  Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. , 1991, The American journal of physiology.

[46]  J. Larosa,et al.  Effects of Conjugated Equine Estrogen With and Without Three Different Progestogens on Lipoproteins, High-Density Lipoprotein Subfractions, and Apolipoprotein A-I , 1991, Obstetrics and gynecology.

[47]  B. O’Malley,et al.  Steroid receptor family: structure and functions. , 1990, Endocrine reviews.

[48]  C. Clarke,et al.  Progestin regulation of cellular proliferation. , 1990, Endocrine reviews.

[49]  C. Shively,et al.  Oral Contraceptives and Coronary Artery Atherosclerosis of Cynomolgus Monkeys , 1990, Obstetrics and Gynecology.

[50]  E. Baulieu.  Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor , 1989 .

[51]  G. Greene,et al.  Progesterone receptors in the human heart and great vessels. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[52]  R. King.  Structure and function of steroid receptors. , 1987, The Journal of endocrinology.

[53]  R. Sharma,et al.  The effects of ovariectomy and subsequent progesterone replacement on the uterus of the pregnant mouse. , 1983, Journal of anatomy.

[54]  H. Mcgill,et al.  Hormone Receptors of the Baboon Cardiovascular System: Biochemical Characterization of Aortic and Myocardial Cytoplasmic Progesterone Receptors , 1982, Circulation research.

[55]  H. Mcgill,et al.  Hormone Receptors of the Baboon Cardiovascular System: Biochemical Characterization of Myocardial Cytoplasmic Androgen Receptors , 1981, Circulation research.

[56]  G. Jenster,et al.  Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. , 1997, Recent progress in hormone research.

[57]  B. O’Malley,et al.  Endocrine defects in mice carrying a null mutation for the progesterone receptor gene. , 1997, Endocrinology.

[58]  E D Verrier,et al.  Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. , 1997, The Annals of thoracic surgery.

[59]  Ján,et al.  Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. , 1995, JAMA.

[60]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.

[61]  L. Martin,et al.  Effect of early ovariectomy and steroid hormone replacement of embryo transport, development and implantation in mice. , 1991, Reproduction, fertility, and development.

[62]  M. Reidy,et al.  Regulation of Smooth Muscle Cell Growth in Injured Artery , 1989, Journal of cardiovascular pharmacology.

[63]  G. Chalepakis,et al.  Gene regulation by steroid hormones. , 1989, Cell.

[64]  M. Press,et al.  Structure and dynamics of the estrogen receptor. , 1986, Journal of steroid biochemistry.